worldwide offices | contact | help | site map

Novartis Pharmaceuticals Corporation - A site intended for US audiences

 

 

 

Diseases & Conditions

PrintTell a FriendtextDecrease text sizeIncrease text size

Back to Index of Diseases & Conditions by Therapeutic Area

ADHD/ADD – Attention Deficit Hyperactivity Disorder

Understanding this condition

Attention-deficit/hyperactivity disorder (ADHD) is a chronic disorder that affects millions of American children, and it can persist into adulthood.

Problems generally associated with ADHD include inattention, hyperactivity and impulsive behavior. They can affect nearly every aspect of life. Children and adults with ADHD often struggle with low self-esteem, troubled personal relationships and poor performance in school or at work.

The best treatment for ADHD is a matter of debate. Currently, psychostimulant drugs are the most commonly prescribed medications for treating ADHD. But although these drugs can relieve many symptoms, they don't cure ADHD, and they can sometimes cause troubling side effects. Counseling, special accommodations in the classroom, and family and community support are other key parts of treatment.

Source: MayoClinic.com

 

Back to Index of Diseases & Conditions
 

OUR PRODUCTS

Products

Novartis is recognized worldwide for bringing to market innovative medicines with improved efficacy and fewer side-effects.

ACCESS TO MEDICINES

Access to Medicines

Novartis puts patients first. We want to create value for all patients, including those who cannot afford treatment. That is why we established Patient Assistance Now, a resource that allows you to access programs that may help you pay for your Novartis medicines.

PATIENT ASSISTANCE PROGRAMS

Patient Assistance Programs

Through our Patient Assistance Programs, we are committed to providing access to our medications for those most in need.